Bloomberg Law quoted Member Joanne Hawana in a recent article about the FDA’s crackdown on potentially misleading drug advertisements following its investigation into the use of social media influencers to promote certain drugs. Attorneys and the telehealth companies they counsel explain in the article that clarity from the FDA is needed on who is responsible for influencer ad messaging, particularly when promoting compounded drugs.

"They haven’t articulated their legal analysis or their legal reasoning, and it is chilling speech to just throw out a hundred letters and then tell everybody you’re coming for them," Joanne says. 

Source

Bloomberg Law